We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.61B
1-Year Est. Return
28.28%
This Fund
S&P 500
This Quarter
Est. Return
+4.62%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.81B
AUM Growth
+$240M
(+15%)
Cap. Flow
+$208M
Cap. Flow
% of AUM
11.48%
Top 10 Holdings %
Top 10 Hldgs %
3.88%
Holding
2,105
New
481
Increased
671
Reduced
539
Closed
400
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$9.12M |
| 2 |
Visa
V
|
+$8.75M |
| 3 |
Motorola Solutions
MSI
|
+$7.37M |
| 4 |
Edwards Lifesciences
EW
|
+$7.3M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$4.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$6.1M |
| 2 |
Bausch Health
BHC
|
+$5.94M |
| 3 |
Deere & Co
DE
|
+$5.72M |
| 4 |
Constellation Brands
STZ
|
+$4.59M |
| 5 |
Qualcomm
QCOM
|
+$4.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.07% |
| 2 | Industrials | 13.48% |
| 3 | Consumer Discretionary | 12.62% |
| 4 | Technology | 11.4% |
| 5 | Financials | 8.62% |
Similar funds
ACB
FWP
RC
SCI
PPW
SCM
BW
GSA Capital Partners's Q2 2016 Portfolio in Review
As of Q2 2016, GSA Capital Partners held 2,105 positions worth $1.81B, up 15% from $1.57B the previous quarter. Its ten largest holdings account for 3.9% of the portfolio.
GSA Capital Partners deployed $208M of net new capital in Q2 2016, opening 481 new positions and adding to 671 existing holdings. Its largest new stake was Mastercard: 95,471 shares worth $8.41M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.
On the sell side, the largest reduction was Bausch Health, an estimated $5.94M trimmed.
- GSA Capital Partners's largest Q2 2016 buy was Mastercard: 95,471 shares worth $8.41M.
- GSA Capital Partners added most to Motorola Solutions in Q2 2016, an estimated $7.37M increase.
- GSA Capital Partners's biggest Q2 2016 reduction was Bausch Health, cutting an estimated $5.94M.
- GSA Capital Partners fully exited Allergan plc in Q2 2016, selling an estimated $6.1M.
- GSA Capital Partners's ten largest holdings make up 3.9% of its $1.81B portfolio in Q2 2016.
- GSA Capital Partners opened 481 new positions and closed 400 in Q2 2016.
- GSA Capital Partners's portfolio value rose 15% quarter-over-quarter to $1.81B.
Based on GSA Capital Partners's 13F filing for Q2 2016, filed 4 Aug 2016.